{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:06:49Z","timestamp":1707523609239},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,30]]},"DOI":"10.7759\/cureus.14182","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T09:06:46Z","timestamp":1617095206000},"source":"Crossref","is-referenced-by-count":0,"title":["A Novel Case of Cytomegalovirus Pneumonia in an Acquired Thrombotic Thrombocytopenic Purpura Patient Treated With Rituximab"],"prefix":"10.7759","author":[{"given":"Emad","family":"Kandah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghunandan","family":"Konda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atefeh","family":"Kalantary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adan","family":"Madadha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind","family":"Kunadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030536","article-title":"Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management","volume":"10","author":"Sukumar S","year":"2021","unstructured":"Sukumar S, L\u00e4mmle B, Cataland SR. Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management. J Clin Med. 2021, 10:536. 10.3390\/jcm10030536","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-01-0193","article-title":"ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients","volume":"102","author":"Vesely SK","year":"2003","unstructured":"Vesely SK, George JN, L\u00e4mmle B, Studt JD, Alberio L, El-Harake MA, Raskob GE. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003, 102:60-8. 10.1182\/blood-2003-01-0193","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly BS","year":"2017","unstructured":"Joly BS, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura. Blood. 2017, 129:2836-46. 10.1182\/blood-2016-10-709857","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2020.1848973","article-title":"Spontaneous recovery in a patient with acquired thrombotic thrombocytopenic purpura (TTP): observation of a 'subclinical' TTP state","volume":"25","author":"Browning S","year":"2020","unstructured":"Browning S, Bahar B, Lee AI, Gorshein E. Spontaneous recovery in a patient with acquired thrombotic thrombocytopenic purpura (TTP): observation of a 'subclinical' TTP state. Hematology. 2020, 25:473-477. 10.1080\/16078454.2020.1848973","journal-title":"Hematology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp053024","article-title":"Clinical practice. Thrombotic thrombocytopenic purpura","volume":"354","author":"George JN","year":"2006","unstructured":"George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med. 2006, 354:1927-35. 10.1056\/NEJMcp053024","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-551580","article-title":"How I treat refractory thrombotic thrombocytopenic purpura","volume":"125","author":"Sayani FA","year":"2015","unstructured":"Sayani FA, Abrams CS. How I treat refractory thrombotic thrombocytopenic purpura. Blood. 2015, 125:3860-7. 10.1182\/blood-2014-11-551580","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2018.1.539","article-title":"Beyond plasma exchange: novel therapies for thrombotic thrombocytopenic purpura","volume":"2018","author":"Dane K","year":"2018","unstructured":"Dane K, Chaturvedi S. Beyond plasma exchange: novel therapies for thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2018, 2018:539-47. 10.1182\/asheducation-2018.1.539","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.02763.x","article-title":"Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab","volume":"50","author":"Caramazza D","year":"2010","unstructured":"Caramazza D, Quintini G, Abbene I, et al.. Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab. Transfusion. 2010, 50:2753-60. 10.1111\/j.1537-2995.2010.02763.x","journal-title":"Transfusion"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06448.x","article-title":"Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13","volume":"136","author":"Scully M","year":"2007","unstructured":"Scully M, Cohen H, Cavenagh J, et al.. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13. Br J Haematol. 2007, 136:451-61. 10.1111\/j.1365-2141.2006.06448.x","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701411441","article-title":"Rituximab-related viral infections in lymphoma patients","volume":"48","author":"Aksoy S","year":"2007","unstructured":"Aksoy S, Harputluoglu H, Kilickap S, Dede DS, Dizdar O, Altundag K, Barista I. Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma. 2007, 48:1307-12. 10.1080\/10428190701411441","journal-title":"Leuk Lymphoma"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.dmih2-0022-2015","article-title":"Cytomegalovirus","volume":"4","author":"Dioverti MV","year":"2016","unstructured":"Dioverti MV, Razonable RR. Cytomegalovirus. Microbiol Spectr. 2016, 4:10.1128\/microbiolspec.dmih2-0022-2015","journal-title":"Microbiol Spectr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002191","article-title":"The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation","volume":"102","author":"Kotton CN","year":"2018","unstructured":"Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, Humar A. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation. Transplantation. 2018, 102:900-31. 10.1097\/TP.0000000000002191","journal-title":"Transplantation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12594","article-title":"Cytomegalovirus infection in solid organ transplant recipients","volume":"20 Suppl 7","author":"Lumbreras C","year":"2014","unstructured":"Lumbreras C, Manuel O, Len O, ten Berge IJ, Sgarabotto D, Hirsch HH. Cytomegalovirus infection in solid organ transplant recipients. Clin Microbiol Infect. 2014, 20 Suppl 7:19-26. 10.1111\/1469-0691.12594","journal-title":"Clin Microbiol Infect"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21484","article-title":"Fatal CMV pneumonitis in a lymphoma patient treated with rituximab","volume":"84","author":"Sharma M","year":"2009","unstructured":"Sharma M, Moore J, Nguyen V, Van Besien K. Fatal CMV pneumonitis in a lymphoma patient treated with rituximab. Am J Hematol. 2009, 84:614-6. 10.1002\/ajh.21484","journal-title":"Am J Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/55644-a-novel-case-of-cytomegalovirus-pneumonia-in-an-acquired-thrombotic-thrombocytopenic-purpura-patient-treated-with-rituximab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:10Z","timestamp":1707506830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/55644-a-novel-case-of-cytomegalovirus-pneumonia-in-an-acquired-thrombotic-thrombocytopenic-purpura-patient-treated-with-rituximab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.14182","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,30]]}}}